Viewing nowCombinationAjustar Tablet 40/10 mg
Telmisartan Powder 23.9% 40mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.

MFDS item code 201607298 · Approved 2016.12.27 · Insurance code 654004840
Treatment of essential hypertension not controlled with monotherapy
This medicine effectively lowers blood pressure in patients with essential hypertension who have difficulty controlling blood pressure with either amlodipine or telmisartan monotherapy. It contributes to the prevention of serious complications such as heart disease and stroke by managing high blood pressure well. Therefore, it is used for the treatment of essential hypertension.
The recommended dose of this medication is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before administering this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with an individual component as described below, switching directly to this medication may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medication 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medication (a combination product with the same amounts of each active ingredient) for convenience (limited to this medication 40/5 mg). ○ Patients with renal impairment: No dosage adjustment is required for patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when administered’). In older adults aged 75 years and above, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medicine should not be used during pregnancy, especially in the second and third trimester, as it may pose a serious risk to the fetus. If pregnancy is confirmed, the use of this medicine should be discontinued as soon as possible. This medicine should not be administered to patients who are allergic to the active ingredient or similar substances, those who are pregnant or may become pregnant, nursing mothers, patients with biliary obstruction, patients with severe liver impairment, patients with serious heart-related diseases, etc. Special caution is required for patients with certain conditions, such as primary aldosteronism, aortic or mitral stenosis, liver disease, gastrointestinal disorders, renal artery hypertension, renal failure, and elderly patients. During the course of treatment with this medicine, side effects such as dizziness, peripheral edema, and hypotension may occur, and if symptoms are severe, consultation with a physician is advised. As this is a blood pressure-lowering drug, symptoms of hypotension may occur, and patients with fluid or salt depletion should check their condition before taking it. This medicine can affect potassium levels in the blood, so patients at risk for hyperkalemia should have regular blood tests. Patients with decreased renal function should periodically monitor for changes in kidney function while taking this medicine. This medicine may interact with other drugs, so it is essential to inform healthcare professionals of any current medications. Drowsiness or dizziness may occur, so caution is advised while driving or operating hazardous machinery. This medicine is not recommended for pediatric patients, and dosage adjustment and careful monitoring are necessary for elderly patients. In case of overdose, symptoms such as hypotension, changes in heart rate, and renal failure may present, requiring immediate medical attention. This medicine should be kept out of the reach of children and must be protected from moisture after opening.
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to light and must be stored in a container that is protected from light. Additionally, it should be stored at a temperature between 1 to 30 degrees Celsius to maintain its effectiveness.
It is a white and light gray, double convex, oval tablet.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 40mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.